Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a leader in microwave ablation technology, successfully participated in the 2025 Microcap Conference in Atlantic City, showcasing its innovative solutions and engaging with over 750 investors and industry experts. The company highlighted its minimally invasive microwave ablation technology and discussed its recent FDA 510(k) clearance for U.S. market expansion. Baird Medical’s leadership held one-on-one meetings with investors to outline growth strategies and explore potential mergers and acquisitions. Chairwoman Haimei Wu emphasized the importance of the conference for fostering global partnerships to enhance patient outcomes through technological advancements.